Vanguard Group’s IGC Pharma IGC Stock Holding History

Vanguard Group’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$323K	Hold	1,149,268	–	–	﹤0.01%	4023
2025 Q3	$479K	Buy	1,149,268 +504,102	+78%	+$192K	﹤0.01%	3961
2025 Q2	$197K	Hold	645,166	–	–	﹤0.01%	4090
2025 Q1	$184K	Hold	645,166	–	–	﹤0.01%	4085
2024 Q4	$217K	Hold	645,166	–	–	﹤0.01%	4093
2024 Q3	$275K	Hold	645,166	–	–	﹤0.01%	4087
2024 Q2	$280K	Hold	645,166	–	–	﹤0.01%	4112
2024 Q1	$258K	Hold	645,166	–	–	﹤0.01%	4138
2023 Q4	$181K	Hold	645,166	–	–	﹤0.01%	4236
2023 Q3	$232K	Sell	645,166 -1,377	-0.2%	-$492	﹤0.01%	4227
2023 Q2	$201K	Hold	646,543	–	–	﹤0.01%	4314
2023 Q1	$220K	Hold	646,543	–	–	﹤0.01%	4305
2022 Q4	$206K	Buy	646,543 +744	+0.1%	+$303	﹤0.01%	4308
2022 Q3	$278K	Hold	645,799	–	–	﹤0.01%	4359
2022 Q2	$343K	Hold	645,799	–	–	﹤0.01%	4373
2022 Q1	$612K	Sell	645,799 -8,929	-1%	-$8.67K	﹤0.01%	4348
2021 Q4	$640K	Buy	654,728 +456	+0.1%	+$612	﹤0.01%	4377
2021 Q3	$968K	Hold	654,272	–	–	﹤0.01%	4253
2021 Q2	$1.07M	Sell	654,272 -60,100	-8%	-$91.7K	﹤0.01%	4137
2021 Q1	$1.28M	Hold	714,372	–	–	﹤0.01%	3957
2020 Q4	$1.11M	Buy	714,372 +243,941	+52%	+$360K	﹤0.01%	3800
2020 Q3	$489K	Buy	470,431 +16,321	+4%	+$16.6K	﹤0.01%	3823
2020 Q2	$272K	Hold	454,110	–	–	﹤0.01%	3885
2020 Q1	$223K	Hold	454,110	–	–	﹤0.01%	3845
2019 Q4	$286K	Hold	454,110	–	–	﹤0.01%	3887
2019 Q3	$441K	Hold	454,110	–	–	﹤0.01%	3842
2019 Q2	$745K	Buy	+454,110	New	+$642K	﹤0.01%	3751

Other funds holding IGC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group's IGC Position: Q4 2025 in Review

Vanguard Group held its IGC Pharma (IGC) position steady in Q4 2025 at 1,149,268 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #4023.

Vanguard Group first reported a position in IGC in Q2 2019 and has held it in 27 quarters since. The position peaked at $1.28M in Q1 2021. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

Vanguard Group held 1,149,268 shares of IGC Pharma worth $323K as of Q4 2025.
Vanguard Group left its IGC Pharma share count unchanged in Q4 2025.
IGC Pharma made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4023 holding.
Vanguard Group first reported a position in IGC Pharma in Q2 2019 and has held it in 27 quarters since.
Vanguard Group's IGC Pharma position peaked at $1.28M in Q1 2021.
30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.